Association of BNP and Troponin Levels with Outcome among Cardiac Resynchronization Therapy Recipients

We conducted a prospective multicenter study to assess the prognostic value of combined baseline preimplant plasma levels of the biomarkers cardiac troponin T (TnT) and B‐type natriuretic peptide (BNP) among cardiac resynchronization therapy (CRT) with or without defibrillator capability (CRT‐D) recipients.

[1]  S. Solomon,et al.  Brain Natriuretic Peptide and Cardiac Resynchronization Therapy in Patients With Mildly Symptomatic Heart Failure , 2013, Circulation. Heart failure.

[2]  S. Aakhus,et al.  Prognostic value of cardiac troponin T in patients with moderate to severe heart failure scheduled for cardiac resynchronization therapy. , 2011, American heart journal.

[3]  Wojciech Zareba,et al.  Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.

[4]  M. Gold,et al.  Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. , 2009, Journal of the American College of Cardiology.

[5]  A. Shalaby,et al.  Usefulness of Brain Natriuretic Peptide Level at Implant in Predicting Mortality in Patients with Advanced But Stable Heart Failure Receiving Cardiac Resynchronization Therapy , 2009, Clinical cardiology.

[6]  Stefano Ghio,et al.  Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. , 2008, Journal of the American College of Cardiology.

[7]  N. Freemantle,et al.  Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial. , 2008, Journal of the American College of Cardiology.

[8]  E. Fleck,et al.  Functional capacity and changes in the neurohormonal and cytokine status after long-term CRT in heart failure patients. , 2007, International journal of cardiology.

[9]  Nick Freemantle,et al.  Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: a pre-defined analysis from the CARE-HF trial. , 2007, European heart journal.

[10]  M. Zahid,et al.  Detectable Troponin Levels Predict Poor Prognosis in Patients With Left Ventricular Dysfunction Undergoing Internal Defibrillator Implantation , 2007, Pacing and clinical electrophysiology : PACE.

[11]  J. Daubert,et al.  Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony. , 2006, European heart journal.

[12]  G. Fonarow,et al.  Usefulness of preimplantation B-type natriuretic peptide level for predicting response to cardiac resynchronization therapy. , 2007, American Journal of Cardiology.

[13]  J. Kautzner,et al.  Decrease in plasma B‐type natriuretic peptide early after initiation of cardiac resynchronization therapy predicts clinical improvement at 12 months , 2006, European journal of heart failure.

[14]  B. Radovancević,et al.  Brain natriuretic peptide levels and response to cardiac resynchronization therapy in heart failure patients. , 2006, Congestive heart failure.

[15]  C. Forleo,et al.  Prognostic value of brain natriuretic peptide in the management of patients receiving cardiac resynchronization therapy , 2006, European journal of heart failure.

[16]  R. Strasser,et al.  Long term biventricular resynchronisation therapy in advanced heart failure: effect on neurohormones , 2005, Heart.

[17]  D. DeMets,et al.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[18]  Gabriel Thabut,et al.  Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. , 2004, Journal of the American College of Cardiology.

[19]  G. Fonarow,et al.  Cardiac Troponin I Is Associated With Impaired Hemodynamics, Progressive Left Ventricular Dysfunction, and Increased Mortality Rates in Advanced Heart Failure , 2003, Circulation.

[20]  D. Delurgio,et al.  Effect of Cardiac Resynchronization Therapy on Left Ventricular Size and Function in Chronic Heart Failure , 2003, Circulation.

[21]  J. Healey,et al.  Prognostic use of cardiac troponin T and troponin I in patients with heart failure. , 2003, The Canadian journal of cardiology.

[22]  P. Hanrath,et al.  Usefulness of brain natriuretic peptide release as a surrogate marker of the efficacy of long-term cardiac resynchronization therapy in patients with heart failure. , 2003, The American journal of cardiology.

[23]  G. Fonarow,et al.  Combining natriuretic peptides and necrosis markers in determining prognosis in heart failure. , 2003, Reviews in cardiovascular medicine.

[24]  RudolfBerger,et al.  B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart Failure , 2002 .

[25]  H. Naruse,et al.  Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. , 2002, The American journal of cardiology.

[26]  M. Vogeser,et al.  Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. , 2001, Journal of the American College of Cardiology.

[27]  H. Kishida,et al.  Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure. , 1999, The American journal of cardiology.

[28]  M. Kinoshita,et al.  Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. , 1998, American heart journal.